Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Bernardo

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of the American College of Cardiology|October 16, 2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery diseaseDominick J Angiolillo, Esther Bernardo, Manel Sabaté, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 2006
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrelDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Cardiovascular Pharmacology|November 10, 2020
Platelet Apoptotic Response May Be Associated With the Capacity of Aspirin to Inhibit PlateletsJosé J Zamorano-León, Martin Gascón, Carlos H Martínez, et al.
Platelets|November 28, 2006
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
The American Journal of Cardiology|October 24, 2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
Thrombosis Research|September 27, 2005
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
The American Journal of Cardiology|October 11, 2005
Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia geneDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of the American College of Cardiology|October 16, 2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery diseaseDominick J Angiolillo, Esther Bernardo, Manel Sabaté, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 2006
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrelDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Cardiovascular Pharmacology|November 10, 2020
Platelet Apoptotic Response May Be Associated With the Capacity of Aspirin to Inhibit PlateletsJosé J Zamorano-León, Martin Gascón, Carlos H Martínez, et al.
Platelets|November 28, 2006
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
The American Journal of Cardiology|October 24, 2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.
Thrombosis Research|September 27, 2005
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
The American Journal of Cardiology|October 11, 2005
Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia geneDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Pageof 5